Page last updated: 2024-09-03

plavix and bicalutamide

plavix has been researched along with bicalutamide in 1 studies

Compound Research Comparison

Studies
(plavix)
Trials
(plavix)
Recent Studies (post-2010)
(plavix)
Studies
(bicalutamide)
Trials
(bicalutamide)
Recent Studies (post-2010) (bicalutamide)
7051,313212541

Protein Interaction Comparison

ProteinTaxonomyplavix (IC50)bicalutamide (IC50)
Progesterone receptorOryctolagus cuniculus (rabbit)5.6
Progesterone receptorHomo sapiens (human)1.819
Androgen receptorHomo sapiens (human)0.404
Androgen receptorRattus norvegicus (Norway rat)0.7168
Androgen receptorMus musculus (house mouse)1.835
Testosterone 17-beta-dehydrogenase 3Homo sapiens (human)0.12
Progesterone receptorRattus norvegicus (Norway rat)0.89

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1

Other Studies

1 other study(ies) available for plavix and bicalutamide

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013